StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3048% below fair value
$0.51−0.03 (-4.67%)

Close on Nov 17, 2026Market cap $151.09MP/E –Yield –

Invivyd total assets

Total assets on the balance sheet at the end of each period.

Invivyd's total assets was $218.88M at Jun 30, 2026. For fiscal 2025 it was $276.88M, up 113.8% from the year before. The highest annual figure on record is $620.09M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$276.88M+113.8%
FY2024Dec 31, 2024$129.52M-43.5%
FY2023Dec 31, 2023$229.18M-40.2%
FY2022Dec 31, 2022$383.17M-38.2%
FY2021Dec 31, 2021$620.09M+428.3%
FY2020Dec 31, 2020$117.38M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$218.88M+145.6%
Q1 FY2026Mar 31, 2026$241.74M+133.0%
Q4 FY2025Dec 31, 2025$276.88M+113.8%
Q3 FY2025Sep 30, 2025$139.16M-14.1%
Q2 FY2025Jun 30, 2025$89.14M-49.7%
Q1 FY2025Mar 31, 2025$103.74M-51.9%
Q4 FY2024Dec 31, 2024$129.52M-43.5%
Q3 FY2024Sep 30, 2024$161.92M-41.1%
Q2 FY2024Jun 30, 2024$177.35M-43.8%
Q1 FY2024Mar 31, 2024$215.47M-38.5%
Q4 FY2023Dec 31, 2023$229.18M-40.2%
Q3 FY2023Sep 30, 2023$274.92M-35.3%
Q2 FY2023Jun 30, 2023$315.41M-34.9%
Q1 FY2023Mar 31, 2023$350.56M-37.0%
Q4 FY2022Dec 31, 2022$383.17M-38.2%
Q3 FY2022Sep 30, 2022$424.75M-38.1%
Q2 FY2022Jun 30, 2022$484.61M+21.8%
Q1 FY2022Mar 31, 2022$556.27M+373.9%
Q4 FY2021Dec 31, 2021$620.09M–
Q3 FY2021Sep 30, 2021$686.27M–
Q2 FY2021Jun 30, 2021$397.99M–
Q4 FY2020Dec 31, 2020$117.38M–

More Invivyd figures

See a number that looks wrong?